These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1508606)

  • 1. Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency.
    Couper RT; Corey M; Moore DJ; Fisher LJ; Forstner GG; Durie PR
    Pediatr Res; 1992 Aug; 32(2):179-82. PubMed ID: 1508606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of the pancreas in cystic fibrosis.
    Durie PR
    Neth J Med; 1992 Oct; 41(3-4):97-100. PubMed ID: 1470291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
    Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exocrine pancreatic function in cystic fibrosis.
    Guy-Crotte O; Carrère J; Figarella C
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):755-9. PubMed ID: 8864671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
    Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
    Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of pancreatic function by magnetic resonance in cystic fibrosis.
    Heijerman HG; Tjon a Tham RT; Bakker W; Falke TH; Lamers CB
    Neth J Med; 1993 Aug; 43(1-2):59-63. PubMed ID: 8232695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the pancreatic and respiratory functions in cystic fibrosis. The influence of the time of the evolution of the disease].
    Ericson N; Navarro S; Valderrama R; Adrián MJ; Lloberes P; Cobos N
    Med Clin (Barc); 1993 Nov; 101(17):650-2. PubMed ID: 8289509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype.
    Walkowiak J; Lisowska A; Blaszczyński M
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):157-60. PubMed ID: 18301292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic polypeptide in cystic fibrosis.
    Nousia-Arvanitakis S; Tomita T; Desai N; Kimmel JR
    Arch Pathol Lab Med; 1985 Aug; 109(8):722-6. PubMed ID: 3893382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubeless tests of exocrine pancreatic function in patients with cystic fibrosis.
    Lamers CB
    Neth J Med; 1992 Oct; 41(3-4):101-4. PubMed ID: 1470277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exocrine pancreatic function on resting energy expenditure in cystic fibrosis.
    Moudiou T; Galli-Tsinopoulou A; Nousia-Arvanitakis S
    Acta Paediatr; 2007 Oct; 96(10):1521-5. PubMed ID: 17880419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program.
    Waters DL; Dorney SF; Gaskin KJ; Gruca MA; O'Halloran M; Wilcken B
    N Engl J Med; 1990 Feb; 322(5):303-8. PubMed ID: 2296272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein dilaurate test of exocrine pancreatic function in cystic fibrosis.
    Dalzell AM; Heaf DP
    Arch Dis Child; 1990 Jul; 65(7):788-9. PubMed ID: 2386387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis.
    Baker SS; Borowitz D; Duffy L; Fitzpatrick L; Gyamfi J; Baker RD
    J Pediatr; 2005 Feb; 146(2):189-93. PubMed ID: 15689904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional management of cystic fibrosis patients.
    Kalnins D; Durie PR; Pencharz P
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):348-54. PubMed ID: 17414506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting energy expenditure in cystic fibrosis as an indicator of disease severity.
    Moudiou T; Galli-Tsinopoulou A; Vamvakoudis E; Nousia-Arvanitakis S
    J Cyst Fibros; 2007 Apr; 6(2):131-6. PubMed ID: 16844432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.